ENTITY: - **Agilent Technologies**
DATE: 13-03-2026

**Forensic Audit Memo – Agilent Technologies (Genomic Analysis)**

**Objective:** Assess data integrity, chain of custody, and compliance with regulatory standards (e.g., FDA, ISO 17025) in genomic analysis workflows.

**Scope:** Review sample handling, instrument calibration, software validation, and audit trail documentation for traceability.

**Findings:** Identified discrepancies in batch logging and potential calibration drift in mass spectrometry systems; no evidence of intentional data manipulation.

**Recommendations:** Implement automated logging for real-time audit trails and quarterly recalibration of critical instruments to mitigate risks.

**Approval:** [Your Name/Title]
**Date:** [Insert Date]

[NOTARIZED BY 2A AGENCY]